October, 02 2018, 12:00am EDT
For Immediate Release
Contact:
Ben Lilliston,Communications Director,(612) 870-3416,blilliston@iatp.org
'New NAFTA' Falls Flat for Farmers, Food Advocates
The reworked agreement between the United States, Mexico and Canada neglects the demands of farm groups
MINNEAPOLIS
In response to the release of the text of a "New NAFTA," now called the United States-Mexico-Canada Agreement (USMCA) between the three North American nations, IATP Executive Director Juliette Majot issued the following statement:
"The reworked NAFTA agreement entrenches agribusiness control over supply chains, seeks to streamline approval and trade of controversial agricultural biotechnology products, fails to protect consumers' right to know what's in their food and where it is produced, and worsens the devastating impacts of climate change.
IATP and our allies in farming communities in the United States, Canada and Mexico have demanded a different kind of trade deal for decades. We want trade rules that support strong, sustainable and fair food systems and rural economies.
This reworked agreement achieves none of this.
One of the key sticking points was the U.S. demand that Canada dismantle its successful dairy supply management program. The Canadian government has agreed to end certain restrictions on dairy imports and grant additional market access for U.S. dairy. These concessions will weaken the Canadian system with no clear benefit for U.S. dairy farmers, especially the small, family farms bearing the brunt of the current crisis.
The U.S. dairy crisis stems from massive oversupply produced through mega-sized dairy operations where dairy farmers continue to suffer from prices below the cost of production. In Canada, the supply management system has kept a majority of dairy farms in the hands of family farmers, without reliance on public subsidies. Trade agreements and the U.S. Farm Bill should prioritize local production and rural livelihoods. Weakening Canada's successful supply management program will do nothing to achieve those goals.
Rather than doubling down on policies already proven unsuccessful, the U.S. should be negotiating for Mexico and Canada to stop opposing Country of Origin Labeling (COOL) for meat. COOL would restore consumers' right to know where their food is produced and help U.S. ranchers and food workers bargain for fair prices and wages in a struggling agricultural economy. Instead, new language in the text requires that measures like COOL be the least trade restrictive possible, rather than the most effective to satisfy public interest.
The reworked agreement squandered key opportunities to address agricultural dumping across borders and to reform NAFTA's enforcement system. This enforcement system sustains oil, gas and other industry challenges to governmental environment and climate policies in corporate-friendly forums where they seek billions of dollars in damages for claimed lost profits. While we welcome the phasing out of Canadian firms from this unjust mechanism, it leaves Mexican and U.S. energy and climate policies vulnerable to future legal challenges.
Any agreement will ultimately be judged on whether it contributes to fair and sustainable outcomes for the people of each country.
Up to now, IATP and other trade watchdogs have had to rely on bits and pieces of information about the actual text of NAFTA and the wish lists submitted by hundreds of corporations, which together pointed to a deal based on the rejected Trans-Pacific Partnership. We will examine the newly released text in detail and provide analyses on the ramifications of this deal for emerging food technologies, food labels that truly inform consumers and the rules we need to protect our soil, waterways and public health."
The Institute for Agriculture and Trade Policy works locally and globally at the intersection of policy and practice to ensure fair and sustainable food, farm and trade systems.
LATEST NEWS
Dems Demand Answers as Trump Photo Disappears From DOJ Online Epstein Files
"What else is being covered up?"
Dec 20, 2025
Congressional Democrats on Saturday pressed US Attorney General Pam Bondi for answers regarding the apparent removal of a photo showing President Donald Trump surrounded by young female models from Friday's Department of Justice release of files related to the late convicted child sex criminal Jeffrey Epstein.
Amid the heavily redacted documents in Friday's DOJ release was a photo of a desk with an open drawer containing multiple photos of Trump, including one of him with Epstein and convicted child sex trafficker Ghislaine Maxwell and another of him with the models.
However, the photo—labeled EFTA00000468 in the DOJ's Epstein Library—was no longer on the site as of Saturday morning.
"This photo, file 468, from the Epstein files that includes Donald Trump, has apparently now been removed from the DOJ release," Democrats on the House Oversight Committee noted in a Bluesky post. "AG Bondi, is this true? What else is being covered up? We need transparency for the American public."
This photo, file 468, from the Epstein files that includes Donald Trump has apparently now been removed from the DOJ release.AG Bondi, is this true? What else is being covered up? We need transparency for the American public.
[image or embed]
— Oversight Dems (@oversightdemocrats.house.gov) December 20, 2025 at 9:30 AM
Numerous critics have accused the Trump administration of a cover-up due to the DOJ's failure to meet a Friday deadline to release all Epstein-related documents and heavy redactions—including documents of 100 pages or more that are completely blacked out—to many of the files.
Deputy Attorney General Todd Blanche responded to the criticism by claiming that "the only redactions being applied to the documents are those required by law—full stop."
"Consistent with the statute and applicable laws, we are not redacting the names of individuals or politicians unless they are a victim," he added.
Earlier this year, officials at the Federal Bureau of Investigation reportedly redacted Trump's name from its file on Epstein, who was the president's longtime former friend and who died in 2019 in a New York City jail cell under mysterious circumstances officially called suicide while facing federal child sex trafficking and conspiracy charges.
Trump has not been accused of any crimes in connection with Epstein.
House Oversight Committee Ranking Member Robert Garcia (D-Calif.) said during a Friday CNN interview that the DOJ only released about 10% of the full Epstein files.
The DOJ is breaking the law by not releasing the full Epstein files. This is not transparency. This is just more coverup by Donald Trump and Pam Bondi. They need to release all the files, NOW.
[image or embed]
— Congressman Robert Garcia (@robertgarcia.house.gov) December 19, 2025 at 5:06 PM
"The DOJ has had months and hundreds of agents to put these files together, and yet entire documents are redacted—from the first word to the last," Garcia said on X. "What are they hiding? The American public deserves transparency. Release all the files now!"
In a joint statement Friday, Garcia and House Judiciary Committee Ranking Member Jamie Raskin (D-Md.) said, "We are now examining all legal options in the face of this violation of federal law."
"The survivors of this nightmare deserve justice, the co-conspirators must be held accountable, and the American people deserve complete transparency from DOJ," they added.
Rep. Ro Khanna (D-Calif.)—who along with Rep. Thomas Massie (R-Ky.) introduced the Epstein Files Transparency Act, which was signed into law by Trump last month and required the release of all Epstein materials by December 19—said in a video published after Friday's document dump that he and Massie "are exploring all options" to hold administration officials accountable.
"It can be the impeachment of people at Justice, inherent contempt, or referring for prosecution those who are obstructing justice," he added.
Keep ReadingShow Less
Israeli Forces Massacre 6 Palestinians Celebrating Wedding at Gaza School Shelter
"This isn't a truce, it's a bloodbath," said a relative of some of the victims, who included women, an infant, and a teenage girl.
Dec 20, 2025
Funerals were held Saturday in northern Gaza for six people, including children, massacred the previous day by Israeli tank fire during a wedding celebration at a school sheltering displaced people, as the number of Palestinians killed during the tenuous 10-week ceasefire rose to over 400.
On Friday, an Israel Defense Forces (IDF) tank blasted the second floor of the Gaza Martyrs School, which was housing Palestinians displaced by the two-year war on Gaza in the al-Tuffah neighborhood of Gaza City.
Al Jazeera and other news outlets reported that the attack occurred while people were celebrating a wedding.
Al-Shifa Hospital director Mohammed Abou Salmiya said those slain included a 4-month-old infant, a 14-year-old girl, and two women. At least five others were injured in the attack.
"It was a safe area and a safe school and suddenly... they began firing shells without warning, targeting women, children and civilians," Abdullah Al-Nader—who lost relatives including 4-month-old Ahmed Al-Nader in the attack—told Agence France-Presse.
Witnesses said IDF troops subsequently blocked first responders including ambulances and civil defense personnel from reaching the site for over two hours.
"We gathered the remains of children, elderly, infants, women, and young people," Nafiz al-Nader, another relative of the infant and others killed in Friday's attack, told reporters. "Unfortunately, we called the ambulance and the civil defense, but they couldn't get by the Israeli army."
The IDF said that “during operational activity in the area of the Yellow Line in the northern Gaza Strip, a number of suspicious individuals were identified in command structures," and that "troops fired at the suspicious individuals to eliminate the threat."
The Yellow Line is a demarcation boundary between areas of Gaza under active Israeli occupation—more than half of the strip's territory, including most agricultural and strategic lands—and those under the control of Hamas.
"The claim of casualties in the area is familiar; the incident is under investigation," the IDF said, adding that it "regrets any harm to uninvolved parties and acts as much as possible to minimize harm to them."
Since the October 7, 2023 Hamas-led attack on Israel, more than 250,000 Palestinians have been killed or wounded by Israeli forces, including approximately 9,500 people who are missing and presumed dead and buried beneath rubble. Classified IDF documents suggest that more than 80% of the Palestinians killed by Israeli forces were civilians.
Around 2 million Palestinians have also been displaced—on average, six times—starved, or sickened in the strip.
Gaza officials say at least 401 Palestinians have been killed since a US-brokered ceasefire between Israel and Hamas took effect on October 10. Gaza's Government Media Office says Israel has violated the ceasefire at least 738 times.
"This isn't a truce, it's a bloodbath," Nafiz al-Nader told Agence France-Presse outside al-Shifa Hospital on Saturday.
Israel says Hamas broke the truce at least 32 times, with three IDF soldiers killed during the ceasefire.
Israeli Prime Minister Benjamin Netanyahu and Yoav Gallant, his former defense minister, are fugitives from the International Criminal Court in The Hague, where they are wanted for alleged war crimes and crimes against humanity in Gaza, including murder and forced starvation.
Israel is also facing a genocide case filed by South Africa at the International Court of Justice, also in The Hague. A United Nations commission, world leaders, Israeli and international human rights groups, jurists, and scholars from around the world have called Israel's war on Gaza a genocide.
Friday's massacre came as Steve Witkoff, President Donald Trump's Mideast envoy, other senior US officials, and representatives of Egypt, Qatar, Turkey, and the United Arab Emirates met in Miami to discuss the second phase of Trump's peace plan, which includes the deployment of an international stabilization force, disarming Hamas, the withdrawal of IDF troops from the strip, and the establishment of a new government there.
Keep ReadingShow Less
Trump's 9 New Prescription Drug Deals 'No Substitute' for Systemic Reform
"Patients are overwhelmingly calling on Congress to do more to lower prescription drug prices by holding Big Pharma accountable and addressing the root causes of high drug prices," said one campaigner.
Dec 19, 2025
"Starting next year, American drug prices will come down fast and furious and will soon be the lowest in the developed world," President Donald Trump claimed Friday as the White House announced agreements with nine pharmaceutical manufacturers.
The administration struck most favored nation (MFN) pricing deals with Amgen, Bristol Myers Squibb, Boehringer Ingelheim, Genentech, Gilead Sciences, GSK, Merck, Novartis, and Sanofi. The president—who has launched the related TrumpRx.gov—previously reached agreements with AstraZeneca, EMD Serono, Eli Lilly, Novo Nordisk, and Pfizer.
"The White House said it has made MFN deals with 14 of the 17 biggest drug manufacturers in the world," CBS News noted Friday. "The three drugmakers that were not part of the announcement are AbbVie, Johnson & Johnson, and Regeneron, but the president said that deals involving the remaining three could be announced at another time."
However, as Trump and congressional Republicans move to kick millions of Americans off of Medicaid and potentially leave millions more uninsured because they can't afford skyrocketing premiums for Affordable Care Act (ACA) plans, some critics suggested that the new drug deals with Big Pharma are far from enough.
"When 47% of Americans are concerned they won't be able to afford a healthcare cost next year, steps to reduce drug prices for patients are welcomed, especially by patients who rely on one of the overpriced essential medicines named in today's announcement," said Merith Basey, CEO of Patients for Affordable Drugs Now, in a statement.
"But voluntary agreements with drug companies—especially when key details remain undisclosed—are no substitute for durable, system-wide reforms," Basey stressed. "Patients are overwhelmingly calling on Congress to do more to lower prescription drug prices by holding Big Pharma accountable and addressing the root causes of high drug prices, because drugs don't work if people can't afford them."
As the New York Times reported Friday:
Drugs that will be made available in this way include Amgen's Repatha, for lowering cholesterol, at $239 a month; GSK's asthma inhaler, Advair Diskus, at $89 a month; and Merck's diabetes medication Januvia, at $100 a month.
Many of these drugs are nearing the end of their patent protection, meaning that the arrival of low-cost generic competition would soon have prompted manufacturers to lower their prices.
In other cases, the direct-buy offerings are very expensive and out of reach for most Americans.
For example, Gilead will offer Epclusa, a three-month regimen of pills that cures hepatitis C, for $2,492 a month on the site. Most patients pay far less using insurance or with help from patient assistance programs. Gilead says on its website that "typically a person taking Epclusa pays between $0 and $5 per month" with commercial insurance or Medicare.
While medication prices are a concern for Americans who face rising costs for everything from groceries to utility bills, the outcome of the ongoing battle on Capitol Hill over ACA tax credits—which are set to expire at the end of the year—is expected to determine how many people can even afford to buy health insurance for next year.
The ACA subsidies fight—which Republicans in the US House of Representatives ignored in the bill they passed this week before leaving Capitol Hill early—has renewed calls for transitioning the United States from its current for-profit healthcare system to Medicare for All.
"At the heart of our healthcare crisis is one simple truth: Corporations have too much power over our lives," Rep. Pramila Jayapal (D-Wash.), former chair of the Congressional Progressive Caucus, said on social media Friday. "Medicare for All is how we take our power back and build a system that puts people over profits."
Jayapal reintroduced the Medicare for All Act in April with Rep. Debbie Dingell (D-Mich.) and Senate Health, Education, Labor, and Pensions Committee Ranking Member Bernie Sanders (I-Vt.). The senator said Friday that some of his top priorities in 2026 will be campaign finance reform, income and wealth inequality, the rapid deployment of artificial intelligence, and Medicare for All.
Earlier this month, another backer of that bill, US Sen. Chris Van Hollen (D-Md.), said: "We must stop tinkering around the edges of a broken healthcare system. Yes, let's extend the ACA tax credits to prevent a huge spike in healthcare costs for millions. Then, let's finally create a system that puts your health over corporate profits. We need Medicare for All."
It's not just progressives in Congress demanding that kind of transformation. According to Data for Progress polling results released late last month, 65% of likely US voters—including 78% of Democrats, 71% of Independents, and 49% of Republicans—either strongly or somewhat support "creating a national health insurance program, sometimes called 'Medicare for All.'"
Keep ReadingShow Less
Most Popular


